Mutton D E, Alberman E, Ide R, Bobrow M
Department of Epidemiology and Medical Statistics, London Hospital Medical College.
BMJ. 1991 Nov 23;303(6813):1295-7. doi: 10.1136/bmj.303.6813.1295.
To examine the feasibility of a national register of Down's syndrome and its effectiveness in evaluating prenatal screening for the syndrome.
Information for the register was obtained from all eligible cytogenetic laboratories on relevant cytogenetic diagnoses, including date and place of birth or termination, maternal age, indication for karyotyping, and type of diagnostic test used.
Cytogenetic laboratories in England and Wales.
All fetuses with trisomy 21 diagnosed prenatally and live births with Down's syndrome diagnosed at birth.
Number of prenatal and postnatal diagnoses of Down's syndrome. National and maternal age specific prevalence of Down's syndrome.
For 1989 there were 1060 registrations--323 prenatal diagnoses and 737 postnatal diagnoses--after exclusion of postnatally diagnosed miscarriages and stillbirths. The estimated national rate of affected births for mothers resident in England and Wales was 1.4/1000 live births, assuming no terminations of affected pregnancies and after correction for natural losses which would have occurred in the absence of termination. The corrected maternal age specific rates were close to those found in previous population based studies. The proportion of affected pregnancies diagnosed prenatally in mothers aged 35 to 39 was 44%, and for those aged 40 or more it was 71%. Abnormal findings on ultrasonography played an unexpectedly important part in initiating cytogenetic investigation (13% of the prenatal diagnoses).
The findings establish the feasibility of a national Down's syndrome register and its use in evaluating prenatal screening services. Together with information held by the Office of Population Censuses and Surveys on congenital malformations, data from the register will permit studies of environmental variables affecting the prevalence of the syndrome.
研究建立全国唐氏综合征登记册的可行性及其在评估该综合征产前筛查效果方面的作用。
登记册信息取自所有符合条件的细胞遗传学实验室,内容包括相关细胞遗传学诊断,如出生日期或终止妊娠日期及地点、母亲年龄、进行核型分析的指征以及所采用的诊断检测类型。
英格兰和威尔士的细胞遗传学实验室。
所有产前诊断为21三体的胎儿以及出生时诊断为唐氏综合征的活产儿。
唐氏综合征的产前和产后诊断数量。全国及按母亲年龄划分的唐氏综合征患病率。
1989年,排除出生后诊断的流产儿和死胎后,有1060例登记——323例产前诊断和737例产后诊断。假设未终止受影响的妊娠,并对在未终止妊娠情况下自然发生的流产进行校正后,估计居住在英格兰和威尔士的母亲所生受影响婴儿的全国发生率为1.4/1000活产儿。校正后的按母亲年龄划分的发生率与先前基于人群的研究结果相近。35至39岁母亲中产前诊断出受影响妊娠的比例为44%,40岁及以上母亲中这一比例为71%。超声检查异常结果在启动细胞遗传学检查中发挥了出人意料的重要作用(占产前诊断的13%)。
研究结果证实了建立全国唐氏综合征登记册的可行性及其在评估产前筛查服务方面的用途。登记册数据与人口普查和调查办公室掌握的先天性畸形信息相结合,将有助于研究影响该综合征患病率的环境变量。